Thyroid papillary carcinoma after alemtuzumab therapy for MS
- 356 Downloads
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Conflicts of interest
The authors declare that there is no conflict of interest.
The authors have complied with the journal’s ethical policies.